Health R&D spending for major Western countries appears to have slowed, while emerging market economies China and South Korea continue to accelerate investment, and has Japan. Flat growth in the U.S. looks even worse when adjusted for inflation (see "Facing Reality," A5). In Germany and France, two of the largest economies in Europe, the average annual growth rate in government budget appropriations or outlays for R&D (GBAORD) in